Featured Research

from universities, journals, and other organizations

Mayo Clinic Researchers Invent 'Hitchhiking' Viruses As Cancer Drug Delivery System

Date:
September 19, 2005
Source:
Mayo Clinic
Summary:
A Mayo Clinic research team has devised a new virus-based gene therapy delivery system to help fight cancer. Researchers say their findings will help overcome hurdles that have hindered gene therapy cancer treatments.

ROCHESTER, Minn. -- A Mayo Clinic research team has devised a newvirus-based gene therapy delivery system to help fight cancer.Researchers say their findings will help overcome hurdles that havehindered gene therapy cancer treatments.

The Mayo research team, which includes a collaborator from theUnited Kingdom, describes its new approach in the current edition ofNature Medicine (http://www.nature.com/nm/index.html).

The approach relies on "therapeutic hitchhikers" -- particlesderived from retroviruses (RNA-containing viruses that incorporate intothe genomes of infected cells and then produce a therapeutic gene). Theviral particles attach to a specific kind of T cell in the immunesystem and "hitchhike" to the tumor because T cells home in on tumorsnaturally; T cells are the immune system's major line of defenseagainst tumors. By hitching a ride on the T cells, the therapeuticparticles can hit their tumor target while avoiding detection (anddestruction) by the immune system. When the Mayo team experimented withthe hitchhiking approach in mice using human and mouse cancer cells,they observed significant cure rates of metastatic -- or spreading --tumors.

"Any clinical situation in which cells home to disease sites --such as inflammation or autoimmune disease -- might benefit from thisapproach," explains Richard Vile, Ph.D., Mayo Clinic molecularimmunologist and lead researcher of the investigation. "Our work is animportant contribution to the maturation of the field of gene therapybecause ultimately treating cancers by gene therapy depends onscientists' ability to specifically target tumor cells in the patient-- and this specific-delivery feature has eluded researchers for avariety of reasons. But by devising a way for viruses to hitch rides onantigen-specific T cells, we've been able to get over multipleobstacles to gene therapy."

Dr. Vile emphasizes that the work is still experimental and notyet ready for use in human patients. But if larger studies validatethese findings, the therapeutic hitchhiker approach may be employed inclinical trials of new treatments.

Significance of the Mayo Research

The Mayo investigators have invented a simpler method for usingmodified viruses to transport therapeutic genes to tumors. They are thefirst to exploit traits of retroviruses during the infection process ofa cell in which attachment to the cell can occur in a nonspecific way.This opens up new opportunities for using viruses therapeuticallybecause this method of attachment allows researchers not only to targetparticular cells, but also to more easily gain entry into the cells --which they must do to deliver therapeutic genes to destroy tumors. TheT cells also help kill tumors.

About the Investigation

Using mice, the Mayo Clinic team showed that retrovirusparticles could successfully attach to the surface of primary T cellsand then safely hitchhike -- be carried through the bodies of mice thathad fully functioning immune systems and evade detection by the immunesystem -- to reach tumors, the sites of T cell accumulation. Theyfurther showed that once it reached the tumor, the viral transportersuccessfully transferred a gene to both mouse and human tumor cellsthat then infected the cells. This proved that the concept works.

Collaboration and Support

In addition to Dr. Vile, the Mayo Clinic research team includedCaroline Cole, Ph.D.; Jian Qiao, M.D., Ph.D.; Timothy Kottke; RosaMaria Diaz, Ph.D.; Atique Ahmed; Luis Sanchez-Perez; Gregory Brunn,Ph.D.; and Jill Thompson. John Chester, M.B.B.S., Ph.D., collaboratedfrom the Cancer Research UK Clinical Center, St. James' UniversityHospital, Leeds, UK. The work was supported by grants from MayoFoundation and the National Institutes of Health.



Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Researchers Invent 'Hitchhiking' Viruses As Cancer Drug Delivery System." ScienceDaily. ScienceDaily, 19 September 2005. <www.sciencedaily.com/releases/2005/09/050919081820.htm>.
Mayo Clinic. (2005, September 19). Mayo Clinic Researchers Invent 'Hitchhiking' Viruses As Cancer Drug Delivery System. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2005/09/050919081820.htm
Mayo Clinic. "Mayo Clinic Researchers Invent 'Hitchhiking' Viruses As Cancer Drug Delivery System." ScienceDaily. www.sciencedaily.com/releases/2005/09/050919081820.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins